Annual Total Long Term Liabilities
$1.75 B
-$1.46 M-0.08%
31 December 2023
Summary:
BridgeBio Pharma annual total long term liabilities is currently $1.75 billion, with the most recent change of -$1.46 million (-0.08%) on 31 December 2023. During the last 3 years, it has risen by +$1.77 million (+0.10%). BBIO annual total long term liabilities is now -0.08% below its all-time high of $1.75 billion, reached on 31 December 2022.BBIO Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Long Term Liabilities
$1.74 B
+$2.05 M+0.12%
30 September 2024
Summary:
BridgeBio Pharma quarterly total long term liabilities is currently $1.74 billion, with the most recent change of +$2.05 million (+0.12%) on 30 September 2024. Over the past year, it has dropped by -$918.00 thousand (-0.05%). BBIO quarterly long term liabilities is now -0.36% below its all-time high of $1.75 billion, reached on 31 March 2022.BBIO Quarterly Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
BBIO Long Term Liabilities Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | -0.1% |
| 3 y3 years | +0.1% | +0.1% |
| 5 y5 years | +1730.8% | +1729.8% |
BBIO Long Term Liabilities High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -0.1% | +0.1% | -0.4% | +0.5% |
| 5 y | 5 years | -0.1% | +1730.8% | -0.4% | +1729.8% |
| alltime | all time | -0.1% | +3072.7% | -0.4% | +3071.1% |
BridgeBio Pharma Long Term Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $1.74 B(+0.1%) |
| June 2024 | - | $1.74 B(-0.1%) |
| Mar 2024 | - | $1.74 B(-0.0%) |
| Dec 2023 | $1.75 B(-0.1%) | $1.75 B(+0.1%) |
| Sept 2023 | - | $1.74 B(-0.0%) |
| June 2023 | - | $1.74 B(+0.0%) |
| Mar 2023 | - | $1.74 B(-0.2%) |
| Dec 2022 | $1.75 B(+0.2%) | $1.75 B(+0.4%) |
| Sept 2022 | - | $1.74 B(+0.2%) |
| June 2022 | - | $1.74 B(-0.8%) |
| Mar 2022 | - | $1.75 B(+0.4%) |
| Dec 2021 | $1.74 B | $1.74 B(+22.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2021 | - | $1.42 B(+1.2%) |
| June 2021 | - | $1.41 B(+1.3%) |
| Mar 2021 | - | $1.39 B(+177.3%) |
| Dec 2020 | $500.05 M(+424.6%) | $500.05 M(+1.3%) |
| Sept 2020 | - | $493.60 M(+1.8%) |
| June 2020 | - | $485.07 M(+2.6%) |
| Mar 2020 | - | $472.81 M(+396.0%) |
| Dec 2019 | $95.32 M(+73.3%) | $95.32 M(+24.8%) |
| Sept 2019 | - | $76.41 M(-86.2%) |
| June 2019 | - | $554.39 M(+903.6%) |
| Mar 2019 | - | $55.24 M(+0.4%) |
| Dec 2018 | $55.00 M(-61.9%) | $55.00 M |
| Dec 2017 | $144.18 M | - |
FAQ
- What is BridgeBio Pharma annual total long term liabilities?
- What is the all time high annual total long term liabilities for BridgeBio Pharma?
- What is BridgeBio Pharma quarterly total long term liabilities?
- What is the all time high quarterly long term liabilities for BridgeBio Pharma?
- What is BridgeBio Pharma quarterly long term liabilities year-on-year change?
What is BridgeBio Pharma annual total long term liabilities?
The current annual total long term liabilities of BBIO is $1.75 B
What is the all time high annual total long term liabilities for BridgeBio Pharma?
BridgeBio Pharma all-time high annual total long term liabilities is $1.75 B
What is BridgeBio Pharma quarterly total long term liabilities?
The current quarterly long term liabilities of BBIO is $1.74 B
What is the all time high quarterly long term liabilities for BridgeBio Pharma?
BridgeBio Pharma all-time high quarterly total long term liabilities is $1.75 B
What is BridgeBio Pharma quarterly long term liabilities year-on-year change?
Over the past year, BBIO quarterly total long term liabilities has changed by -$918.00 K (-0.05%)